Form 8-K - Current report:
SEC Accession No. 0001104659-21-042458
Filing Date
2021-03-26
Accepted
2021-03-26 16:19:29
Documents
13
Period of Report
2021-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2110937d1_8k.htm   iXBRL 8-K 46231
  Complete submission text file 0001104659-21-042458.txt   288273

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrk-20210323.xsd EX-101.SCH 4498
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20210323_def.xml EX-101.DEF 28712
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20210323_lab.xml EX-101.LAB 38996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20210323_pre.xml EX-101.PRE 27321
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2110937d1_8k_htm.xml XML 8752
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 21777661
SIC: 2834 Pharmaceutical Preparations